The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
The global Antibody-drug Conjugates market was valued at US$ 2831.3 million in 2023 and is anticipated to reach US$ 3919.8 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.
North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.
The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.
This report aims to provide a comprehensive presentation of the global market for Antibody-drug Conjugates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody-drug Conjugates.
Report Scope
The Antibody-drug Conjugates market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody-drug Conjugates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody-drug Conjugates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- ImmunoGen
- Seattle Genetics
- Roche
- Takeda
Segment by Type
- Adcetris
- Kadcyla
Segment by Application
- Breast Cancer
- Lymphoma
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antibody-drug Conjugates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antibody-drug Conjugates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Antibody-drug Conjugates Market Overview
1.1 Product Overview and Scope of Antibody-drug Conjugates
1.2 Antibody-drug Conjugates Segment by Type
1.2.1 Global Antibody-drug Conjugates Market Value Comparison by Type (2024-2030)
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Antibody-drug Conjugates Segment by Application
1.3.1 Global Antibody-drug Conjugates Market Value by Application: (2024-2030)
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Global Antibody-drug Conjugates Market Size Estimates and Forecasts
1.4.1 Global Antibody-drug Conjugates Revenue 2019-2030
1.4.2 Global Antibody-drug Conjugates Sales 2019-2030
1.4.3 Global Antibody-drug Conjugates Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antibody-drug Conjugates Market Competition by Manufacturers
2.1 Global Antibody-drug Conjugates Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antibody-drug Conjugates Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antibody-drug Conjugates Average Price by Manufacturers (2019-2024)
2.4 Global Antibody-drug Conjugates Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antibody-drug Conjugates, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antibody-drug Conjugates, Product Type & Application
2.7 Antibody-drug Conjugates Market Competitive Situation and Trends
2.7.1 Antibody-drug Conjugates Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antibody-drug Conjugates Players Market Share by Revenue
2.7.3 Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antibody-drug Conjugates Retrospective Market Scenario by Region
3.1 Global Antibody-drug Conjugates Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antibody-drug Conjugates Global Antibody-drug Conjugates Sales by Region: 2019-2030
3.2.1 Global Antibody-drug Conjugates Sales by Region: 2019-2024
3.2.2 Global Antibody-drug Conjugates Sales by Region: 2025-2030
3.3 Global Antibody-drug Conjugates Global Antibody-drug Conjugates Revenue by Region: 2019-2030
3.3.1 Global Antibody-drug Conjugates Revenue by Region: 2019-2024
3.3.2 Global Antibody-drug Conjugates Revenue by Region: 2025-2030
3.4 North America Antibody-drug Conjugates Market Facts & Figures by Country
3.4.1 North America Antibody-drug Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antibody-drug Conjugates Sales by Country (2019-2030)
3.4.3 North America Antibody-drug Conjugates Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antibody-drug Conjugates Market Facts & Figures by Country
3.5.1 Europe Antibody-drug Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antibody-drug Conjugates Sales by Country (2019-2030)
3.5.3 Europe Antibody-drug Conjugates Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antibody-drug Conjugates Market Facts & Figures by Country
3.6.1 Asia Pacific Antibody-drug Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antibody-drug Conjugates Sales by Country (2019-2030)
3.6.3 Asia Pacific Antibody-drug Conjugates Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antibody-drug Conjugates Market Facts & Figures by Country
3.7.1 Latin America Antibody-drug Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antibody-drug Conjugates Sales by Country (2019-2030)
3.7.3 Latin America Antibody-drug Conjugates Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antibody-drug Conjugates Market Facts & Figures by Country
3.8.1 Middle East and Africa Antibody-drug Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antibody-drug Conjugates Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antibody-drug Conjugates Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antibody-drug Conjugates Sales by Type (2019-2030)
4.1.1 Global Antibody-drug Conjugates Sales by Type (2019-2024)
4.1.2 Global Antibody-drug Conjugates Sales by Type (2025-2030)
4.1.3 Global Antibody-drug Conjugates Sales Market Share by Type (2019-2030)
4.2 Global Antibody-drug Conjugates Revenue by Type (2019-2030)
4.2.1 Global Antibody-drug Conjugates Revenue by Type (2019-2024)
4.2.2 Global Antibody-drug Conjugates Revenue by Type (2025-2030)
4.2.3 Global Antibody-drug Conjugates Revenue Market Share by Type (2019-2030)
4.3 Global Antibody-drug Conjugates Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antibody-drug Conjugates Sales by Application (2019-2030)
5.1.1 Global Antibody-drug Conjugates Sales by Application (2019-2024)
5.1.2 Global Antibody-drug Conjugates Sales by Application (2025-2030)
5.1.3 Global Antibody-drug Conjugates Sales Market Share by Application (2019-2030)
5.2 Global Antibody-drug Conjugates Revenue by Application (2019-2030)
5.2.1 Global Antibody-drug Conjugates Revenue by Application (2019-2024)
5.2.2 Global Antibody-drug Conjugates Revenue by Application (2025-2030)
5.2.3 Global Antibody-drug Conjugates Revenue Market Share by Application (2019-2030)
5.3 Global Antibody-drug Conjugates Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ImmunoGen
6.1.1 ImmunoGen Corporation Information
6.1.2 ImmunoGen Description and Business Overview
6.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ImmunoGen Antibody-drug Conjugates Product Portfolio
6.1.5 ImmunoGen Recent Developments/Updates
6.2 Seattle Genetics
6.2.1 Seattle Genetics Corporation Information
6.2.2 Seattle Genetics Description and Business Overview
6.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Seattle Genetics Antibody-drug Conjugates Product Portfolio
6.2.5 Seattle Genetics Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Antibody-drug Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Antibody-drug Conjugates Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Corporation Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Antibody-drug Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Takeda Antibody-drug Conjugates Product Portfolio
6.4.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antibody-drug Conjugates Industry Chain Analysis
7.2 Antibody-drug Conjugates Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antibody-drug Conjugates Production Mode & Process
7.4 Antibody-drug Conjugates Sales and Marketing
7.4.1 Antibody-drug Conjugates Sales Channels
7.4.2 Antibody-drug Conjugates Distributors
7.5 Antibody-drug Conjugates Customers
8 Antibody-drug Conjugates Market Dynamics
8.1 Antibody-drug Conjugates Industry Trends
8.2 Antibody-drug Conjugates Market Drivers
8.3 Antibody-drug Conjugates Market Challenges
8.4 Antibody-drug Conjugates Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
